• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

机构信息

Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

出版信息

JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.

DOI:10.1001/jama.2020.5394
PMID:32250385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7136855/
Abstract

IMPORTANCE

In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. Information about the clinical characteristics of infected patients who require intensive care is limited.

OBJECTIVE

To characterize patients with coronavirus disease 2019 (COVID-19) requiring treatment in an intensive care unit (ICU) in the Lombardy region of Italy.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective case series of 1591 consecutive patients with laboratory-confirmed COVID-19 referred for ICU admission to the coordinator center (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) of the COVID-19 Lombardy ICU Network and treated at one of the ICUs of the 72 hospitals in this network between February 20 and March 18, 2020. Date of final follow-up was March 25, 2020.

EXPOSURES

SARS-CoV-2 infection confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swabs.

MAIN OUTCOMES AND MEASURES

Demographic and clinical data were collected, including data on clinical management, respiratory failure, and patient mortality. Data were recorded by the coordinator center on an electronic worksheet during telephone calls by the staff of the COVID-19 Lombardy ICU Network.

RESULTS

Of the 1591 patients included in the study, the median (IQR) age was 63 (56-70) years and 1304 (82%) were male. Of the 1043 patients with available data, 709 (68%) had at least 1 comorbidity and 509 (49%) had hypertension. Among 1300 patients with available respiratory support data, 1287 (99% [95% CI, 98%-99%]) needed respiratory support, including 1150 (88% [95% CI, 87%-90%]) who received mechanical ventilation and 137 (11% [95% CI, 9%-12%]) who received noninvasive ventilation. The median positive end-expiratory pressure (PEEP) was 14 (IQR, 12-16) cm H2O, and Fio2 was greater than 50% in 89% of patients. The median Pao2/Fio2 was 160 (IQR, 114-220). The median PEEP level was not different between younger patients (n = 503 aged ≤63 years) and older patients (n = 514 aged ≥64 years) (14 [IQR, 12-15] vs 14 [IQR, 12-16] cm H2O, respectively; median difference, 0 [95% CI, 0-0]; P = .94). Median Fio2 was lower in younger patients: 60% (IQR, 50%-80%) vs 70% (IQR, 50%-80%) (median difference, -10% [95% CI, -14% to 6%]; P = .006), and median Pao2/Fio2 was higher in younger patients: 163.5 (IQR, 120-230) vs 156 (IQR, 110-205) (median difference, 7 [95% CI, -8 to 22]; P = .02). Patients with hypertension (n = 509) were older than those without hypertension (n = 526) (median [IQR] age, 66 years [60-72] vs 62 years [54-68]; P < .001) and had lower Pao2/Fio2 (median [IQR], 146 [105-214] vs 173 [120-222]; median difference, -27 [95% CI, -42 to -12]; P = .005). Among the 1581 patients with ICU disposition data available as of March 25, 2020, 920 patients (58% [95% CI, 56%-61%]) were still in the ICU, 256 (16% [95% CI, 14%-18%]) were discharged from the ICU, and 405 (26% [95% CI, 23%-28%]) had died in the ICU. Older patients (n = 786; age ≥64 years) had higher mortality than younger patients (n = 795; age ≤63 years) (36% vs 15%; difference, 21% [95% CI, 17%-26%]; P < .001).

CONCLUSIONS AND RELEVANCE

In this case series of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Lombardy, Italy, the majority were older men, a large proportion required mechanical ventilation and high levels of PEEP, and ICU mortality was 26%.

摘要

重要性

2019 年 12 月,一种新型冠状病毒(严重急性呼吸系统综合征冠状病毒 2 [SARS-CoV-2])在中国出现,并已在全球范围内传播,造成大流行。有关需要重症监护的感染患者的临床特征的信息有限。

目的

描述意大利伦巴第地区需要入住重症监护病房(ICU)的 2019 年冠状病毒病(COVID-19)患者的特征。

设计、地点和参与者:这是一项回顾性病例系列研究,纳入了 1591 例连续确诊的 COVID-19 患者,这些患者经实时逆转录酶-聚合酶链反应(RT-PCR)检测鼻和咽拭子呈阳性,需要转入协调中心(米兰,意大利米兰的 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico),并在该网络的 72 家医院之一的 ICU 接受治疗。最终随访日期为 2020 年 3 月 25 日。

暴露因素

SARS-CoV-2 感染经实时 RT-PCR 检测鼻和咽拭子阳性证实。

主要结果和措施

收集了人口统计学和临床数据,包括临床管理、呼吸衰竭和患者死亡率的数据。COVID-19 伦巴第 ICU 网络的工作人员通过电话记录协调中心的电子工作表上的数据。

结果

在这项研究中,纳入的 1591 例患者的中位(IQR)年龄为 63(56-70)岁,1304 例(82%)为男性。在 1043 例可获得数据的患者中,709 例(68%)至少有一种合并症,509 例(49%)患有高血压。在 1300 例可获得呼吸支持数据的患者中,1287 例(99%[95%CI,98%-99%])需要呼吸支持,包括 1150 例(88%[95%CI,87%-90%])接受机械通气和 137 例(11%[95%CI,9%-12%])接受无创通气。中位呼气末正压(PEEP)为 14(IQR,12-16)cm H2O,89%的患者 Fio2 大于 50%。中位 PaO2/Fio2 为 160(IQR,114-220)。年轻患者(n=503,年龄≤63 岁)和年长患者(n=514,年龄≥64 岁)的中位 PEEP 水平无差异(分别为 14[IQR,12-15]和 14[IQR,12-16]cm H2O;中位数差值,0[95%CI,0-0];P=0.94)。年轻患者的中位 Fio2 较低:60%(IQR,50%-80%)vs 70%(IQR,50%-80%)(中位数差值,-10%[95%CI,-14%至 6%];P=0.006),年轻患者的中位 PaO2/Fio2 较高:163.5(IQR,120-230)vs 156(IQR,110-205)(中位数差值,7[95%CI,-8 至 22];P=0.02)。患有高血压的患者(n=509)比没有高血压的患者(n=526)年龄更大(中位数[IQR]年龄,66 岁[60-72]vs 62 岁[54-68];P<0.001),PaO2/Fio2 更低(中位数[IQR],146[105-214]vs 173[120-222];中位数差值,-27[95%CI,-42 至-12];P=0.005)。截至 2020 年 3 月 25 日,可获得 ICU 处置数据的 1581 例患者中,920 例(58%[95%CI,56%-61%])仍在 ICU,256 例(16%[95%CI,14%-18%])已从 ICU 出院,405 例(26%[95%CI,23%-28%])已死亡。年龄较大的患者(n=786;年龄≥64 岁)的死亡率高于年龄较小的患者(n=795;年龄≤63 岁)(36%vs 15%;差异,21%[95%CI,17%-26%];P<0.001)。

结论和相关性

在这项针对意大利伦巴第地区入住 ICU 的确诊 COVID-19 危重症患者的病例系列研究中,大多数患者为年龄较大的男性,其中很大一部分需要机械通气和高水平的 PEEP,ICU 死亡率为 26%。

相似文献

1
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
2
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
3
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
6
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.西班牙感染新型冠状病毒肺炎(SARS-CoV-2)的危重症患者的特征、临床病程及与重症监护病房(ICU)死亡率相关的因素:一项前瞻性队列多中心研究
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13.
7
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
8
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.意大利米兰 COVID-19 急性呼吸窘迫综合征有创通气患者的特征、治疗、结局和死亡原因。
Crit Care Resusc. 2020 Sep;22(3):200-211. doi: 10.1016/S1441-2772(23)00387-3.
9
Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.加拿大温哥华 ICU 收治的 COVID-19 患者的基线特征和结局:一项病例系列研究。
CMAJ. 2020 Jun 29;192(26):E694-E701. doi: 10.1503/cmaj.200794. Epub 2020 May 27.
10
Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a "Pandemic Ready" Intensive Care Unit - Lessons from Singapore.收治于“抗疫准备充分”的重症监护病房的呼吸衰竭 COVID-19 患者的特征和结局——来自新加坡的经验教训。
Ann Acad Med Singap. 2020 Jul;49(7):434-448.

引用本文的文献

1
Cancer disparities: Projection, COVID-19, and scenario-based diagnosis delay impact.癌症差异:预测、COVID-19 以及基于情景的诊断延迟影响
PLoS One. 2025 Sep 2;20(9):e0330752. doi: 10.1371/journal.pone.0330752. eCollection 2025.
2
Breathless Aftermath: Post-COVID-19 Pulmonary Fibrosis.气喘吁吁的后果:新冠后肺纤维化
Viruses. 2025 Aug 9;17(8):1098. doi: 10.3390/v17081098.
3
SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment.严重急性呼吸综合征冠状病毒2型肺炎:诊断与治疗进展
Microorganisms. 2025 Jul 31;13(8):1791. doi: 10.3390/microorganisms13081791.
4
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients.新冠病毒病的非病毒疗法:我们目前的进展如何?我们在新冠病毒病方面的经验如何有助于我们为长期新冠患者开发细胞疗法。
Biomedicines. 2025 Jul 23;13(8):1801. doi: 10.3390/biomedicines13081801.
5
Genetic liability to systemic inflammatory regulators is causally linked to COVID-19 diverse phenotypes: Insights from multi-omics association study and single-cell RNA sequencing analysis.全身炎症调节因子的遗传易感性与新冠病毒病的多种表型存在因果关系:多组学关联研究和单细胞RNA测序分析的见解
Medicine (Baltimore). 2025 Aug 22;104(34):e44089. doi: 10.1097/MD.0000000000044089.
6
Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study.接受药物免疫抑制治疗患者的新冠病毒感染结局。一项瑞士队列研究。
Arch Med Sci. 2022 Aug 3;21(3):845-851. doi: 10.5114/aoms/152340. eCollection 2025.
7
Comparative Analysis of Severe Clinical Outcomes in Hospitalized Patients with RSV, Influenza, and COVID-19 Across Early and Late COVID-19 Pandemic Phases (2021-2024).2021 - 2024年新冠疫情早期和晚期住院的呼吸道合胞病毒、流感和新冠病毒感染患者严重临床结局的比较分析
J Clin Med. 2025 Jul 10;14(14):4894. doi: 10.3390/jcm14144894.
8
Severe ARDS Complicated by Active Pulmonary Tuberculosis and Recurrent Nosocomial Infections: Therapeutic Challenges and Clinical Outcomes.重症急性呼吸窘迫综合征合并活动性肺结核及反复医院感染:治疗挑战与临床结局
Life (Basel). 2025 Jul 4;15(7):1068. doi: 10.3390/life15071068.
9
Plasma Soluble ST2 as a Prognostic Biomarker for Cardiovascular Events and Mortality in COVID-19 Patients.血浆可溶性ST2作为COVID-19患者心血管事件和死亡率的预后生物标志物。
J Cardiovasc Dev Dis. 2025 Jul 17;12(7):273. doi: 10.3390/jcdd12070273.
10
Convalescent plasma therapy for COVID-19 in patients with nasal catheter oxygen therapy.鼻导管吸氧的COVID-19患者的恢复期血浆治疗
J Thorac Dis. 2025 Jun 30;17(6):3532-3546. doi: 10.21037/jtd-2024-1991. Epub 2025 Jun 11.

本文引用的文献

1
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.意大利伦巴第大区新冠疫情期间的重症监护利用情况:应急响应中的早期经验与预测
JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.
4
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
5
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
The variability of critical care bed numbers in Europe.欧洲重症监护病床数量的变化。
Intensive Care Med. 2012 Oct;38(10):1647-53. doi: 10.1007/s00134-012-2627-8. Epub 2012 Jul 10.